Ginseng is known as the king of all herbs in terms of antioxidant and anti-inflammatory activities and recently has become more involved in the treatment of neurological diseases. In this regard, this study aimed to determine the effects of Ginsenosides on pentylenetetrazol-induced epilepsy during the estrus cycle. For this purpose, 30 rats were randomly divided into five groups, namely control (saline), valproic acid (VPA, 75 mg/kg), Ginsenosides (50 mg/kg), Ginsenosides (100 mg/kg), and Ginsenosides (150 mg/kg) with four subgroups (proestrus, estrus, metestrus, and diestrus). Subsequently, the initiation time of myoclonic seizures (ITMS), initiation time of tonic-clonic seizures (ITTS), and seizure duration (SD) were determined. According to the results, ITMS and ITTS significantly increased in the VPA-treated group (P<0.05). Ginsenosides (100 and 150 mg/kg) administration significantly increased ITMS and ITTS (P<0.05). Moreover, the ITMS and ITTS in Ginsenosides-treated rats were significantly higher in luteal phases, compared to the follicular phase (P<0.05). In addition, pretreatment with VPA significantly decreased SD, compared to the control group (P<0.05). A significant decrease in SD was observed in the rats pretreated with ginsenosides (100 and 150 mg/kg) (P<0.05). Seizure duration significantly decreased in animals that received Ginsenosides in luteal phases, compared to the follicular phase (P<0.05). These results suggested that Ginsenosides have anticonvulsant effects that are more prominent during the luteal phase than the follicular phase. |
- Ratan ZA, Haidere MF, Hong YH, Park SH, Lee JO, Lee J, et al. Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res. 2021;45(2):199-210.
- Cho HJ, Choi SH, Kim HJ, Lee BH, Rhim H, Kim HC, et al. Bioactive lipids in gintonin-enriched fraction from ginseng. J Ginseng Res. 2019;43(2):209-17.
- Zheng M, Xin Y, Li Y, Xu F, Xi X, Guo H, et al. Ginsenosides: A Potential Neuroprotective Agent. Biomed Res Int. 2018;2018:8174345.
- Mony TJ, Elahi F, Choi JW, Park SJ. Neuropharmacological Effects of Terpenoids on Preclinical Animal Models of Psychiatric Disorders: A Review. Antioxidants (Basel). 2022;11(9).
- Beghi E. The Epidemiology of Epilepsy. Neuroepidemiology. 2020;54(2):185-91.
- Frank S, Tyson NA. A Clinical Approach to Catamenial Epilepsy: A Review. Perm J. 2020;24:1-3.
- Joshi S, Kapur J. Neurosteroid regulation of GABA(A) receptors: A role in catamenial epilepsy. Brain Res. 2019;1703:31-40.
- Stephen LJ, Harden C, Tomson T, Brodie MJ. Management of epilepsy in women. Lancet Neurol. 2019;18(5):481-91.
- Shrivastava A, Gupta J, Goyal M. Flavonoids and antiepileptic drugs: A comprehensive review on their neuroprotective potentials. 2022;11:4179-86.
- Kim JY, Kim JH, Lee HJ, Kim SH, Jung YJ, Lee HY, et al. Antiepileptic and anti-neuroinflammatory effects of red ginseng in an intrahippocampal kainic acid model of temporal lobe epilepsy demonstrated by electroencephalography. Yeungnam Univ J Med. 2018;35(2):192-8.
- Lian XY, Zhang ZZ, Stringer JL. Anticonvulsant activity of ginseng on seizures induced by chemical convulsants. Epilepsia. 2005;46(1):15-22.
- Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16(2):109-10.
- Mattson RH, Cramer JA. Epilepsy, sex hormones, and antiepileptic drugs. Epilepsia. 1985;26(1):40-51.
- Kaboutari J, Zendehdel M, Habibian S, Azimi M, Shaker M, Karimi B. The antiepileptic effect of sodium valproate during different phases of the estrous cycle in PTZ-induced seizures in rats. J Physiol Biochem. 2012;68(2):155-61.
- Zanboori A, Tamaddonfard E, Mojtahedin A. The effect of intracerebroventricular injection of histamine in visceral nociception induced by acetic acid in rats. Indian J Pharmacol. 2010;42(5):289-92.
- Zhang H, Li Z, Zhou Z, Yang H, Zhong Z, Lou C. Antidepressant-like effects of ginsenosides: A comparison of ginsenoside Rb3 and its four deglycosylated derivatives, Rg3, Rh2, compound K, and 20(S)-protopanaxadiol in mice models of despair. Pharmacol Biochem Behav. 2016;140:17-26.
- Zhang YL, Liu Y, Kang XP, Dou CY, Zhuo RG, Huang SQ, et al. Ginsenoside Rb1 confers neuroprotection via promotion of glutamate transporters in a mouse model of Parkinson's disease. Neuropharmacology. 2018;131:223-37.
- Voinescu PE. Catamenial Epilepsy. In: O’Neal MA, editor. Neurology and Psychiatry of Women: A Guide to Gender-based Issues in Evaluation, Diagnosis, and Treatment. Cham: Springer International Publishing; 2019. p. 85-94.
- Reddy DS, Carver CM, Clossen B, Wu X. Extrasynaptic gamma-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures. Epilepsia. 2019;60(4):730-43.
- Bi D, Wen L, Wu Z, Shen Y. GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease. Alzheimers Dement. 2020;16(9):1312-29.
- Kim S, Rhim H. Ginsenosides inhibit NMDA receptor-mediated epileptic discharges in cultured hippocampal neurons. Arch Pharm Res. 2004;27(5):524-30.
- Mehvari-Habibabadi J, Zare M, Aghaye-Ghazvini MR, Rahnama M. The effect of levetiracetam on depression and anti-oxidant activity in patients with epilepsy. Curr J Neurol. 2022;21(4):224.
- Liu Y, Zong X, Huang J, Guan Y, Li Y, Du T, et al. Ginsenoside Rb1 regulates prefrontal cortical GABAergic transmission in MPTP-treated mice. Aging (Albany NY). 2019;11(14):5008-34.
- Kamali M, Zendehdel M, Babapour V, Heshmatian B. The Effect of Gestational Exposure of Sodium Cromoglycate on Epileptiform Activities in the Rat Offspring. Iran J Vet Med. 2018;12(3).
- Azadi A, Zendehdel M, Kaboutari J, Panahi N, Asghari A. Central Phoenixin Protective Role on Pentylenetetrazol-Induced Seizures during Various Stages of the Estrous Cycle among Rats. Arch Razi Inst. 2022;77(2):689.
- Fazlelahi Z, Kaboutari J, Zendehdel M, Panahi N. Effects of Intracerebroventricular Injection of the Steroidal and Non-Steroidal Anti-Inflammatory Drugs on the Seizures during the Estrous Cycle in Rat. Arch Razi Inst. 2023;78(3).
|